Although the original Minnesota multiphasic personality inventory (MMPI) showed promise in.the psychometric discrimination of patients with epileptic seizures and pseudoseizures, inconsistencies and relatively low rates of accuracy have been reported. The present study evaluated the restandardized MMP1-2 for its accuracy in discriminating patients with pseudoseizures in a population with intractable epilepsy. MMPI-2 profiles for 139 consecutive adult inpatients (24 with pseudoseizures) were classified as a pseudoseizure pattern if they had (a) a T score on Scale 1 and/or 3 -> 65, (b) Scale 1 or 3 in the 2-point high code, and (c) if 1 or 3 was not the highest scale, it was -<6T from the highest scale. Compared to studies using the original MMPI, it was expected the MMPI-2 would more accurately classify patients in each group. Preliminary analyses revealed pseudoseizure patients had a greater history of mental health interventions and were older when their seizure disorder began, relative to the epilepsy patients. A classification accuracy of 92% was found for pseudoseizures and 94% for epilepsy patients. For the pseudoseizure group, clinically meaningful MMPI-2 elevations followed a 3-1-2 pattern. No mean elevations above a T value of 65 were seen in the epilepsy group.
INTRODUCTION
Pseudoseizures (or non-epileptic seizures) are paroxysmal alterations of behaviour which are non-epileptic in origin. Although their clinical manifestation may resemble seizures, characteristic electrographic and other ictal phenomena are missing ~'2. In addition no physiological cause can be readily demonstrated for pseudoseizures 3'4. Prevalence estimates of pseudoseizures range from 5 to 35% of patients thought to have epilepsy 5'6. Although accurate diagnosis of pseudoseizures can be difficult, it is crucial because such individuals may be treated as though they have epilepsy, often leading to inappropriate treatment 7, long delays before treating the presumed psychological problems 8, and unnecessary health care expenses.
At present, reliable diagnosis of pseudoseizures is complex and costly 3"4"~J°-13. Betts and Boden ~4 note that despite sophisticated continuous EEG recording and even depth electrode studies, it "may still be impossible to decide what one is dealing with'. Psychological tests are potentially important adjuncts in diagnosing pseudoseizures ~-'6'~5. The MMPI has been the most consistently-studied measure 6"~6"~7, but others such as the MCMI and the WPSI have occasionally appeared ila the literature 6"t8. The ability of psychological tests to discriminate pseudoseizures from epileptic seizures has been inconsistent. Using MMPI profile analyses, some reports have been unable to discriminate pseudoseizure patients from genuine seizure patients tS'tg. In contrast, Wilkus et al 6 devised three classification rules based on MMPI profiles, and found pseudoseizure patients were correctly classified in 80-90% of cases. Those rules were based on elevations on scales 1 (hypochondriasis) and 3 (hysteria) in various configurations relative to other scales. However a replication study ~9 found no MMPI differences between epileptic and non-epileptic groups. A more recent attempt to resolve these divergent results ~5 only seems to have further confused the picture. Among pseudoseizure patients, scales 1, 2, 3 and 8 were elevated (T >70), but only scale 1 was higher relative to the epileptic group. Using the Wilkus et al 6 MMPI rules for their patients, accurate classification was only 61% for pseudoseizures and 80% for epileptic patients ~5.
These findings suggest that the MMPI has promise in contributing to the diagnosis of pseudoseizures, but that further work is needed. Previous results may have been confusing due to inaccurate diagnosis of the criterion groups, leading to misclassification of patients. Moreover, the original MMPI may to an unknown degree have had measurement limitations within this population. We evaluated the possibility that the advent of the MMPI-2 into clinical practice would increase the accuracy with which pseudoseizure patients can be psychometrically distinguished from epilepsy patients. It was expected that the MMPI-2 would be an improvement over previous MMPI studies in terms of more accurate classification of patients. We predicted it would be at least 85% accurate in identifying both pseudoseizure patients and epilepsy patients. As well, compared to epilepsy patients, the pseudoseizure group was expected to show significantly higher elevations on the hysteria and hypochondriasis scales of the MMPI-2.
METHOD Participants
Patients were 139 consecutive adult (age-> 18 years) admissions to the Epilepsy Unit of University Hospital, a regional epilepsy centre within a tertiary care teaching hospital. The sole exception to this was one pseudoseizure patient who was a psychiatric admission to the same hospital, but who was well-known to the epilepsy service. Pertinent demographic data summarizing these patients are presented in Table 1 . Subjects ranged in age from 18 to 57 years and had an overall mean education of 12.5 years. In the pseudoseizure group there were 13 females (54%) and 11 males (46%). In the epileptic seizure group there were 61 females (53%) and 54 males (47%). Comparisons of these means revealed no statistically significant between-group gender differences.
Diagnosis
Patients were referrals for treatment of intractable seizures to a regional epilepsy service, a large component of which is an inpatient Epilepsy Unit which evaluates patients as candidates for epilepsy surgery. All underwent continuous EEG telemetry along with behavioural observation by medical and technical staff who were intensively trained regarding seizure phenomenology. When seizure activity was suspected, staff examined and recorded patients' responsiveness, memory, language, and behaviour.
Pseudoseizures were diagnosed by a neuroIogist/epileptologist according to two criteria. First, paroxysmal behaviourai disturbances resembling seizures were accompanied by no change (and no epileptiform activity) in the on-going EEG recording on at least two occasions. Second, both the neurologist and the patient agreed that the spells designated as pseudoseizures represented a clinically meaningful problem in the patient's life. As is the case in other centres t L2~, our experience is that patients present with a combination of epilepsy and pseudoseizures. In our pseudoseizure group 13 (54%) had a combination of pseudoseizures and epilepsy, while 11 (46%) had pseudoseizures only.
Patients in the epilepsy group were diagnosed 
Measures

MMPI-2
The Minnesota multiphasic personality inventory-2 (MMPI-2) 2j is widely used to assess psychopathology. It is a restandardization and revision of the original MMPI with item content that is more contemporary and less ambiguous. Uniform T-scores were derived from norms collected on a national census-matched sample of 2600 men and women 2~. The MMPI-2 yields ten clinical scales measuring psychopathology, and also provides content scales. Only the clinical scales were analysed in this study. In addition, a pilot study in our centre indicated no malefemale differences for MMPI-2 scores. For this reason scores for both sexes were combined, and Scale 5 (masculinity-feminity) was not reported. To complete the MMPI-2 the patient must have had a grade 6 English reading level and an IQ greater than 75 (assessed by a routine neuropsychological evaluation).
Procedure
Consecutive epilepsy unit admissions between October 1992 and May 1994 were classified by a neurologist into pseudoseizure and epilepsy groups. The accuracy of sorting MMPI-2 profiles as 'epilepsy' or 'pseudoseizure', according to the classification rule described determined. below, 37 was then Table 1 summarizes relevant demographic data for the two groups. It reveals no statistically significant differences for age, IQ, and years of education. However, pseudoseizure patients were significantly older when their first seizure occurred (23.6 years vs. 14.5 years for epilepsy patients; P = 0.01). A significant difference with respect to psychiatric history also emerged: 71% of pseudoseizure patients had a history of psychiatric or psychological intervention, in contrast to only 31% of epilepsy patients (Chi square (1 df) = 11.53, P = 0.0007).
RESULTS
Demographic
MMPI-2 group differences
Figure 1 portrays profile elevations for the pseudoseizure and epilepsy groups. A multivariate analysis of variance (MANOVA) was conducted to test for an overall between-group effects, revealing a significant Hotellings F (12, 126)= 11.26 . (p --0.001). In evaluating differences between pseudoseizure patients and epilepsy patients on individual scales (summarized in Table 2 ), one-tailed t-tests indicated means for the pseudoseizure group were significantly higher for Scale 1 (hypochondriasis; P=0.0001), Scale 2 (depression; P--0.001), Scale 3 (hysteria; P=0.0001), Scale 4 (psychopathic deviate; P =0.03), and Scale 10 (social introversion/extroversion; P = 0.05).
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Clinically meaningful elevations
As can be seen in Fig. 1 , in the pseudoseizure group scales 1-3-2 (in order of highest elevation) were elevated to a point of clinical significance (i.e. T > 65). There were no clinically significant elevations for the epilepsy patient group.
As is presented in Table 3 , the MMPI-2 correctly identified pseudoseizure patients in 22 of 24 cases (92%) and was in error in the remaining two patients (6%). It correctly identified 94% of epilepsy seizure patients (108 of 115 patients), and was in error in the remaining seven cases (6%).
MMPI-2 classification accuracy DISCUSSION
The next step was to assess the percentage of cases where the MMPI-2 accurately identified pseudoseizures and epilepsy patients. To accomplish this, a classification rule was determined. Previous studies 6 used complex multi-step rules; our MMPI-2 rule was generated with power and simplicity as criteria, utilizing the significant between-group differences described above. A pseudoseizure profile met each of the following criteria: (a) a Tscore on Scale 1 and/or 3 -> 65, (b) Scale 1 or 3 appearing in the 2-point high code, and (c) if 1 or 3 was not the highest scale, it must be -<6T from the highest scale. For example, a 2-1 profile, where both scales 2 and 1 were elevated beyond a T of 65, was classified as 'pseudoseizure' if Scale 1 was no more than 6T less than Scale 2.
It has long been recognized that psychological tests make a major contribution to the diagnosis and management of epilepsy a3. The original version of the MMPI showed great promise in its discrimination between patients with epilepsy and those with pseudoseizures 6 but inconsistencies as well as replication failures had also been reported 19. To our knowledge the present study represents the first published evaluation of the MMPI-2 in the context of identification of pseudoseizures. We found the MMPI-2 to have a high degree of accuracy in classifying both pseudoseizure patients (92%) and patients with epileptic seizures (94%). Only one unpublished report 24 has evaluated the MMPI-2 in this fashion. In a small sample (22 patients with psychogenic seizures and 17 with epileptic sei- pseudoseizure groups were composed of individuals who only had pseudoseizures: patients were excluded if they also had epileptic seizures. By including patients with both pseudoseizures and epileptic seizures we believed we were evaluating a sample more representative of the neurologist's practice. This is because the typical diagnostic question is whether a given patient has pseudoseizures, even though they may also have epilepsy. In the presence of some epileptiform EEG activity, the clinician may suspect pseudoseizures because of factors such as an atypical clinical presentation, absence of an EEG correlate during the seizure symptoms, or a significant psychiatric history. In such cases, where the differentiation is not between 'pure epilepsy' and 'pure pseudoseizures' but rather a mixture of the two, the strength of the present study lies in permitting increased confidence in the diagnosis of pseudoseizures. The MMPI-2 by itself cannot diagnose such a disorder. Instead, our data suggest it can be a clinically useful adjunct, along with other salient signs, in the confident diagnosis of this problem.
Consistent with prior MMPI studies 6"15J6"24, the typical MMPI-2 profile in the pseudoseizure group was a conversion or somatoform pattern with Scales 1 and 3 highest and 2 also elevated. Although conversion and somatoform disorders were the modal profiles (19 of 24), several pseudoseizure patients had dysthymic and depressive MMPI-2 patterns and one had another personality disorder. We therefore do not argue that pseudoseizure patients constitute a homogeneous group. This diversity has also been reported by other authors 2J4`t7. Diagnosis in our cases was based on clinical suspicion and scalp-recorded EEG telemetry. Although some might argue that only invasive recordings with depth or subdural electrodes can provide a definitive diagnosis of pseudoseizures, the advisability of utilizing such practices in every patient is questionable when the clinician already has a reasonable suspicion the patient has pseudoseizures. Further, all of our pseudoseizure patients had reductions or eliminations of their anticonvulsant medication with no accompanying worsening of their disorder.
Much work remains before a clearer understanding of the causes of pseudoseizures is obtained. The present study can be added to a growing literature pointing to the emotional and psychological correlates of this problem. In particular, our data support the MMPI-2 as a reasonably accurate, inexpensive and noninvasive clinical adjunct to the diagnosis of pseudoseizures.
